Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy

<b>Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy</b><br> Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N.<br> <br> National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Mosc...

Full description

Saved in:
Bibliographic Details
Main Authors: Kan N.E (Author), Lomova N.A (Author), Kokoeva D.N (Author)
Format: Book
Published: LCC «Medicine-Inform», 2018-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<b>Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy</b><br> Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N.<br> <br> National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Moscow<br> <br> Vulvovaginal candidiasis is an inflammatory change in the vaginal mucosa caused by a fungal infection due to a significant weakening of the immune system. Vulvovaginal candidiasis occupies one of the leading places among infectious pathologies of the lower segment of the genital tract. A significant prevalence of this pathology is proved by the fact that almost 75% of women experience at least one episode of candidal infection during their lifetime, and in 45% of cases it becomes a disease. Vulvovaginal candidiasis is recorded in 60% of pregnant women. It is more often diagnosed in the first and third trimester, when the hormonal and immune systems undergo significant changes.<br> Recently, the complex preparation Primafungin<sup>®</sup> has been widely and effectively used from the second trimester of pregnancy. A prospective, randomized blind study of 60 pregnant women with vulvovaginal candidiasis established a reliable efficacy of Primafungin<sup>®</sup>, confirmed by the positive dynamics of clinical signs and laboratory results.<br> The use of natamycin-containing drugs in the therapy of vulvovaginal candidiasis during pregnancy is highly effective and has no side effects.<br> <br> <b>Key words:</b> vulvovaginal candidiasis, pregnancy, therapy, natamycin.<br> <b>For citation:</b> Tyutyunnik V.L., Khan N.E., Lomova N.A., Kokoeva D.N. Efficacy and compliance of vulvovaginal candidiasis therapy during pregnancy // RMJ. 2018. № 2(I). P. 54-58.<br>
Item Description:2618-8430
2686-7184